Company intelligence / Profile preview

MK Life

Seoul, Seoul, South Korea

Ownership: Private
Employees: ~25
Development stage: Other

Overview

MK Life Science is a South Korean biotechnology company specializing in the development of regenerative medicines and advanced skincare solutions using stem cell-derived exosome technology. The company's proprietary MK-Exo platform focuses on isolating and optimizing high-purity exosomes for applications in hair loss (alopecia), wound healing, and anti-aging. Beyond its therapeutic pipeline, MK Life Science commercializes bio-cosmetic products and functional ingredients based on its research into cell signaling and tissue regeneration. The firm aims to bridge the gap between basic stem cell research and clinical applications in dermatology and aesthetic medicine.

Therapeutic areas: Dermatology
Modalities: Exosome-based therapyStem cell therapyBiologic
Industry: Biotech

Partnerships

Konkuk University

Beyond the preview

Go deeper on MK Life.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MK Life.

Explore the full profile